Blood Platelet 5-Hydroxytryptamine Levels in Psychiatric Patients
- 1 July 1960
- journal article
- research article
- Published by Royal College of Psychiatrists in Journal of Mental Science
- Vol. 106 (444), 884-890
- https://doi.org/10.1192/bjp.106.444.884
Abstract
The interest of 5-hydroxytryptamine (5HT) for psychiatry arose originally from Gaddum's (8, 9) observation that its peripheral pharmacological actions were antagonized in a highly specific manner by a low concentration of lysergic acid diethylamide (LSD). This led to the hypothesis that the hallucinogenic action of LSD was due to its antagonism to 5HT in the central nervous system (Woolley and Shaw, 21; Gaddum, 7). However, Cerletti and Rothlin (5) subsequently found that brom-LSD, which is not a hallucinogen, was an equally potent antagonist of the peripheral actions of 5HT.Keywords
This publication has 15 references indexed in Scilit:
- BLOOD AND URINARY SEROTONIN AND 5-HYDROXYINDOLE ACETIC ACID LEVELS IN SCHIZOPHRENIC PATIENTS AND NORMAL SUBJECTS1Journal of Nervous & Mental Disease, 1959
- Increase of 5-Hydroxytryptamine in Blood Platelets by Isopropyl-isonicotinic Acid HydrazideNature, 1958
- Platelet 5-Hydroxytryptamine (HT) in Disorders of the BloodBritish Journal of Haematology, 1957
- The effect of drugs on the amounts of substance P and 5‐hydroxytryptamine in mammalian brainThe Journal of Physiology, 1956
- 5‐hydroxytryptamine in normal human plateletsThe Journal of Physiology, 1955
- Role of 5-Hydroxytryptamine in Mental Diseases and its Antagonism to Lysergic Acid DerivativesNature, 1955
- Serotonin Release as a Possible Mechanism of Reserpine ActionScience, 1955
- THE BLOOD PLATELET COUNT IN RELATION TO THE MENSTRUAL CYCLE IN NORMAL WOMENThe American Journal of the Medical Sciences, 1939